Risk Factors and Natural History of Bedside Percutaneous Endoscopic Versus Fluoroscopic Guided Gastrostomy Tubes in Intensive Care Unit Patients
Recommended Citation
Soheim R, Chung S, Chau L, Dix M, Bowman M, Obeid N, Gupta AH, Stanton C. Risk Factors and Natural History of Bedside Percutaneous Endoscopic Versus Fluoroscopic Guided Gastrostomy Tubes in Intensive Care Unit Patients. Surg Endosc 2023; 37:S229-S229.
Document Type
Conference Proceeding
Publication Date
6-7-2023
Publication Title
Surg Endosc
Abstract
Introduction: There is a paucity of literature comparing patients receiving bedside placed percutaneous endoscopic gastrostomy (PEG) versus fluoroscopic guided percutaneous gastrostomy tubes (G-tube) in an intensive care unit (ICU) setting. This study aims to investigate and compare the natural history and complications associated with PEG versus fluoroscopic G-tube placement in ICU patients. Methods: All adult patients admitted in the ICU requiring feeding tube placement at our center from 1/1/2017 to 1/1/2022 were identified through retrospective chart review. Patients with at least 6-months follow-up were included in this study. Descriptive statistics were used to illustrate the cohort's natural history. Adjusting for patient comorbidities, hospital factors, and indications for enteral access, a 1-to-2 propensity score matched cox proportional hazards model was fitted evaluate the treatment effect of bedside PEG tube placement versus G-tube placement on patient complications, 6-month readmission, and 6-month death. Major complications were defined as the need for operative or procedural intervention. Results: This study included 740 patients, with 178 bedside PEG (mean age 59.9 [IQR: 47-68.3] years; 55.9% black race; 63.5% male sex) and 562 fluoroscopic G-tube (62.9 [IQR: 51.1-71.1] years; 42.6% black race; 58.5% male sex) placements. Indication for enteral access was predominantly trauma (23.7%) or respiratory (33.7%) in nature for PEG recipients and neurologic (59.6%) for G-tube recipients. The overall rate of complication was 22.3% (13% PEG, 25.2% G-tube, P = 0.003). The major complication rate was 11.2% (8.5% PEG, 12.1% G-tube, P = 0.09). Most common complications were tube dysfunction (16.7% PEG; 39.4% G-tube; p = 0.04) or dislodgement (58.3% PEG; 40.8% G-tube). The average hospital stay was 30.9 days (IQR: 22.3-45.3) for PEG and 24.7 days (IQR: 17.6-36.9) for G-tube recipients (P<0.001). 55.9% PEG and 45.7% G-tube recipients were discharged to long-term care whereas 5% PEG and 9.6% G-tube recipients were discharged home (p<0.001). After propensity score matching, G-tube recipients had significantly increased risk for all-cause (HR: 2.7, 95% C.I.: 1.56-4.87, P<0.001) and major complications (HR: 2.11, 95% C.I.: 1.05-4.23, P = 0.035). There were no significant differences in 6-month rates of readmission (HR: 0.90, 95% C.I.: 0.58-1.38, P = 0.62) or death (HR: 1.00, 95% C.I.: 0.70-1.44, P = 0.7). Conclusions: The overall rate of complications for ICU patients requiring feeding tube in our cohort was 22.3%. ICU patients receiving fluoroscopic guided percutaneous gastrostomy tube placement had significantly elevated risk of 6-month all-cause and major complications compared to those undergoing bedside percutaneous endoscopic gastrostomy. (Figure Presented).
Volume
37
First Page
S229
Last Page
S229